243 related articles for article (PubMed ID: 18544941)
1. Hepatitis B core-related antigen assay is useful for monitoring the antiviral effects of nucleoside analogue therapy.
Tanaka E; Matsumoto A; Yoshizawa K; Maki N
Intervirology; 2008; 51 Suppl 1():3-6. PubMed ID: 18544941
[TBL] [Abstract][Full Text] [Related]
2. Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients.
Suzuki F; Miyakoshi H; Kobayashi M; Kumada H
J Med Virol; 2009 Jan; 81(1):27-33. PubMed ID: 19031469
[TBL] [Abstract][Full Text] [Related]
3. Measurement of hepatitis B virus core-related antigen is valuable for identifying patients who are at low risk of lamivudine resistance.
Tanaka E; Matsumoto A; Suzuki F; Kobayashi M; Mizokami M; Tanaka Y; Okanoue T; Minami M; Chayama K; Imamura M; Yatsuhashi H; Nagaoka S; Yotsuyanagi H; Kawata S; Kimura T; Maki N; Iino S; Kiyosawa K;
Liver Int; 2006 Feb; 26(1):90-6. PubMed ID: 16420514
[TBL] [Abstract][Full Text] [Related]
4. [Fundamental and clinical evaluation of hepatitis B virus core-related antigen assay by LUMIPULSE f].
Tanaka Y; Takagi K; Hiramatsu K; Naganuma H; Iida T; Takasaka Y; Mizokami M
Rinsho Byori; 2006 Jul; 54(7):692-8. PubMed ID: 16913659
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment.
Rokuhara A; Tanaka E; Matsumoto A; Kimura T; Yamaura T; Orii K; Sun X; Yagi S; Maki N; Kiyosawa K
J Viral Hepat; 2003 Jul; 10(4):324-30. PubMed ID: 12823601
[TBL] [Abstract][Full Text] [Related]
6. [Application of serum hepatitis B virus large surface protein determination in lamivudine anti-viral therapy for patients with hepatitis B].
Li GY; Sheng JL; Huang HJ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):133-5. PubMed ID: 18574538
[TBL] [Abstract][Full Text] [Related]
7. Significance of hepatitis B virus core-related antigen and covalently closed circular DNA levels as markers of hepatitis B virus re-infection after liver transplantation.
Matsuzaki T; Tatsuki I; Otani M; Akiyama M; Ozawa E; Miuma S; Miyaaki H; Taura N; Hayashi T; Okudaira S; Takatsuki M; Isomoto H; Takeshima F; Eguchi S; Nakao K
J Gastroenterol Hepatol; 2013 Jul; 28(7):1217-22. PubMed ID: 23432697
[TBL] [Abstract][Full Text] [Related]
8. Preliminary study on the efficacy and safety of lamivudine and interferon alpha therapy in decreasing serum HBV DNA level in HBV positive transgenic mice during pregnancy.
Li D; Xu DZ; Choi BC; Men K; Zhang JX; Lei XY; Yan YP
J Med Virol; 2005 Jun; 76(2):203-7. PubMed ID: 15834875
[TBL] [Abstract][Full Text] [Related]
9. The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.
Gwak GY; Huh W; Lee DH; Choi MS; Lee JH; Koh KC; Kim SJ; Joh JW; Oh HY
Transplant Proc; 2007 Dec; 39(10):3121-6. PubMed ID: 18089336
[TBL] [Abstract][Full Text] [Related]
10. Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.
Ohkawa K; Takehara T; Kato M; Deguchi M; Kagita M; Hikita H; Sasakawa A; Kohga K; Uemura A; Sakamori R; Yamaguchi S; Miyagi T; Ishida H; Tatsumi T; Hayashi N
J Infect Dis; 2008 Oct; 198(8):1150-8. PubMed ID: 18713056
[TBL] [Abstract][Full Text] [Related]
11. [Construction and application of a genechip method for detection of hepatitis B virus lamivudine-resistant mutants and basal core promotor/Pre-C mutants].
Li B; Zhou BP; Peng JF; Chen LY; Zhang W; Tang W; Wang ZQ; Yin ZH; Xu LM; Luo RL; Li XH; Liu SY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):309-12. PubMed ID: 20108783
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of lamivudine on hepatitis B viral status and liver function in patients with hepatitis B virus-related hepatocellular carcinoma.
Kim JH; Park JW; Koh DW; Lee WJ; Kim CM
Liver Int; 2009 Feb; 29(2):203-7. PubMed ID: 18662281
[TBL] [Abstract][Full Text] [Related]
13. Performance evaluation of new automated hepatitis B viral markers in the clinical laboratory: two quantitative hepatitis B surface antigen assays and an HBV core-related antigen assay.
Park Y; Hong DJ; Shin S; Cho Y; Kim HS
Am J Clin Pathol; 2012 May; 137(5):770-7. PubMed ID: 22523216
[TBL] [Abstract][Full Text] [Related]
14. [Clinical application of microarray technique to quantify the lamivudine-resistant gene mutant of hepatitis B virus].
Huang XT; Zeng AP; Lin F
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):185-7. PubMed ID: 17653332
[TBL] [Abstract][Full Text] [Related]
15. Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor.
Knöll A; Boehm S; Hahn J; Holler E; Jilg W
J Viral Hepat; 2007 Jul; 14(7):478-83. PubMed ID: 17576389
[TBL] [Abstract][Full Text] [Related]
16. Frequent detection of hepatitis B virus variants associated with lamivudine resistance in treated South African patients infected chronically with different HBV genotypes.
Selabe SG; Song E; Burnett RJ; Mphahlele MJ
J Med Virol; 2009 Jun; 81(6):996-1001. PubMed ID: 19382250
[TBL] [Abstract][Full Text] [Related]
17. Trial of lamivudine in hepatitis B surface antigen carriers with persistent hepatitis B core IgM antibody.
Ali HY
Saudi Med J; 2003 Sep; 24(9):996-9. PubMed ID: 12973486
[TBL] [Abstract][Full Text] [Related]
18. Selection of precore mutants during lamivudine treatment in patients with chronic hepatitis B.
Cheong JY; Cho SW; Yoo JH; Hong SP; Kim SO; Yoo WD; Kim JH
Hepatogastroenterology; 2008; 55(84):1029-33. PubMed ID: 18705323
[TBL] [Abstract][Full Text] [Related]
19. Direct detection of lamivudine-resistant hepatitis B virus mutants by a multiplex PCR using dual-priming oligonucleotide primers.
Kim JK; Lee HJ; Lee YJ; Chun JY; Lee IK; Lim YS; Suh DJ; Ko SY; Kim MH; Oh HB
J Virol Methods; 2008 Apr; 149(1):76-84. PubMed ID: 18291537
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology, clinical efficacy and safety of lamivudine in hepatitis B virus infection.
Kumar M; Sarin SK
Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):465-95. PubMed ID: 19072396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
